What are the potential interactions between diphenhydramine (Benadryl) and buspirone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Benadryl and Buspirone Interaction

The concomitant use of diphenhydramine (Benadryl) and buspirone does not have a documented direct pharmacokinetic or pharmacodynamic interaction, but caution is warranted due to additive CNS depressant effects, particularly in older adults.

Key Interaction Considerations

No Direct Drug-Drug Interaction

The FDA label for buspirone does not list diphenhydramine as having a specific interaction 1. Buspirone is primarily metabolized by CYP3A4, while diphenhydramine is metabolized mainly by CYP2D6 2, 3. Since these drugs utilize different metabolic pathways, there is no expected pharmacokinetic interaction through enzyme inhibition or induction.

Additive CNS Effects - The Primary Concern

Both medications have CNS-active properties that can be additive:

  • Diphenhydramine causes sedation, dizziness, and anticholinergic effects (blurred vision, dry mouth, urinary retention, confusion) 4, 5
  • Buspirone can cause dizziness, lightheadedness, and drowsiness, though it is generally less sedating than benzodiazepines 6, 7, 8

The buspirone FDA label specifically states: "Because the effects of concomitant administration of buspirone with most other psychotropic drugs have not been studied, the concomitant use of buspirone with other CNS-active drugs should be approached with caution" 1.

Special Populations at Higher Risk

Older Adults: This combination requires particular caution in geriatric patients. The 2019 AGS Beers Criteria identifies diphenhydramine as a potentially inappropriate medication in older adults due to its strong anticholinergic properties 9, 10. The 2015 AGS guidelines on postoperative delirium specifically list diphenhydramine among medications that should be avoided to prevent delirium 11.

Anticholinergic burden from diphenhydramine can cause:

  • Cognitive impairment and delirium
  • Increased fall risk
  • Urinary retention
  • Constipation
  • Blurred vision 10

Clinical Management Algorithm

When both medications are deemed necessary:

  1. Start with lower doses of both agents and titrate carefully

  2. Monitor closely for:

    • Excessive sedation or drowsiness
    • Dizziness and fall risk
    • Cognitive changes or confusion (especially in older adults)
    • Anticholinergic effects (dry mouth, urinary retention, constipation)
  3. Consider alternatives to diphenhydramine:

    • For allergies: Second-generation antihistamines (cetirizine, loratadine, fexofenadine) have minimal CNS penetration and do not increase sedative effects when combined with other CNS agents 12
    • For sleep: Non-anticholinergic options may be preferable
  4. Avoid in older adults when possible: Given the strong evidence against diphenhydramine use in geriatric populations 9, 11, 10, consider alternative antihistamines or non-pharmacologic approaches

Common Pitfalls to Avoid

  • Underestimating anticholinergic burden: Diphenhydramine has potent anticholinergic effects that are particularly problematic in older adults and can contribute to delirium, falls, and cognitive impairment 10
  • Assuming "over-the-counter means safe": Diphenhydramine's availability without prescription does not diminish its potential for significant adverse effects, especially when combined with other CNS-active medications 2, 3
  • Failing to counsel patients: Patients should be warned about operating vehicles or machinery until they know how the combination affects them 1

References

Guideline

aga institute review of endoscopic sedation.

Gastroenterology, 2007

Guideline

polypharmacy management in older patients.

Mayo Clinic Proceedings, 2021

Research

H1 antihistamines and benzodiazepines. Pharmacological interactions and their impact on cerebral function.

Journal of investigational allergology & clinical immunology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.